NUVI - Resources for norms and standards
Any way you look at it, vaccine quality is critical
- Introducing a vaccine - Policy and Programmatic Considerations
- Current prequalified vaccines
- Guidelines on the Quality, Safety and Efficacy of Dengue Tetravalent Vaccines (Live, Attenuated): Proposed replacement of TRS No. 932, Annex 1, 2011
- Recommendations to Assure the Quality, Safety and Efficacy of BCG Vaccines - Proposed replacemenet of: TRS 745, Annex 2 and Amendment to TRS 771, Annex 12, 2011
- Recommendations to Assure the Quality, Safety and Efficacy of Acellular Pertussis Vaccines - Proposed replacement of: TRS 878, Annex 2, 2011
- Recommendations for the Evaluation of Animal Cell Cultures as Substrates for the Manufacture of Biological Medicinal Products and for the Characterization of Cell Banks, 2010
- Recommendations to Assure the Quality, Safety and Efficacy of Live Attenuated Yellow Fever Vaccines, 2010
- Recommendations to Assure the Quality, Safety & Efficacy of Recombinant Hepatitis B Vaccines, 2010
- Guidelines for Independent Lot Release of Vaccines by Regulatory Authorities, 2010